Filing Details
- Accession Number:
- 0001127602-21-007209
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-23 11:41:21
- Reporting Period:
- 2021-02-19
- Accepted Time:
- 2021-02-23 11:41:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1732091 | Birgit Girshick | 251 Ballardvale Street Wilmington MA 01887 | Corporate Executive Vp | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-02-19 | 1,675 | $73.70 | 31,680 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-02-19 | 1,675 | $293.92 | 30,005 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-02-22 | 308 | $289.55 | 29,697 | No | 4 | F | Direct | |
Common Stock | Disposition | 2021-02-23 | 315 | $283.59 | 29,382 | No | 4 | F | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2021-02-19 | 1,675 | $0.00 | 1,675 | $73.70 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-02-26 | 2021-02-26 | No | 4 | M | Direct |